BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19450077)

  • 1. Health economics of medical devices: opportunities and challenges.
    Simoens S
    J Med Econ; 2008; 11(4):713-7. PubMed ID: 19450077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which barriers prevent the efficient use of resources in medical device sectors?
    Simoens S
    Appl Health Econ Health Policy; 2009; 7(4):209-17. PubMed ID: 19905034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing adoption and affordability of medical devices in Europe.
    Schreyögg J; Bäumler M; Busse R
    Health Policy; 2009 Oct; 92(2-3):218-24. PubMed ID: 19410326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation.
    Lee SS; Salole E
    Value Health; 2014 Jun; 17(4):476-81. PubMed ID: 24969010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of emerging medical devices on the market: a new procedure in Belgium.
    Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
    Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices in Israel today.
    Loznen S; Leib M; Sheffer N
    Med Device Technol; 2003 Nov; 14(9):50-3. PubMed ID: 14682025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value.
    Sorenson C; Drummond M; Burns LR
    Health Aff (Millwood); 2013 Apr; 32(4):788-96. PubMed ID: 23569060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reforming the Belgian market for orthotic braces: what can we learn from the international experience?
    Simoens S; De Coster S; Moldenaers I; Guillaume P; Depoorter A; Van den Steen D; Van de Sande S; Debruyne H; Ramaekers D; Lona M
    Health Policy; 2008 May; 86(2-3):195-203. PubMed ID: 18191275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Government health policy and the diffusion of new medical devices.
    Hillman BJ
    Health Serv Res; 1986 Dec; 21(5):681-711. PubMed ID: 3818311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for greater price transparency in the medical device industry: an economic analysis.
    Hahn RW; Klovers KB; Singer HJ
    Health Aff (Millwood); 2008; 27(6):1554-9. PubMed ID: 18997211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Government regulation of pricing and reimbursement of prescription medicines: results of a recent multi-country review.
    Kingham R; Wheeler J
    Food Drug Law J; 2009; 64(1):101-14. PubMed ID: 19998574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health policy decisions on medical innovations: what role can early economic evaluation play?
    Hartz S; John J
    Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.
    Akpinar I; Jacobs P; Husereau D
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):86-9. PubMed ID: 25989920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 2: coverage.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Oct; 3(10):772-7. PubMed ID: 17412167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Price transparency for medical devices.
    Pauly MV; Burns LR
    Health Aff (Millwood); 2008; 27(6):1544-53. PubMed ID: 18997210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices in Germany.
    Wildau HJ; Grohs B
    Med Device Technol; 1998 Nov; 9(9):34-8. PubMed ID: 10344882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
    Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
    Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic evaluation of medical devices: challenges.
    Kingkaew P; Teerawattananon Y
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S102-7. PubMed ID: 24964706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an equivalent to the National Medicines Policy for medical devices.
    Smith MW; Faunce TA
    J Law Med; 2009 Dec; 17(3):412-25. PubMed ID: 20169801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.